Replies to post #3360 on BrainStorm Cell Therapeutics Inc (BCLI)

[Viewmont]

$BCLI Adding/added!

$BCLI has submitted an IND amendment to the #FDA to support the initiation of a Phase 3b clinical trial evaluating NurOwn® in ALS. This important regulatory milestone reflects our continued commitment to the ALS community and advancing potential treatment options through rigorous… pic.twitter.com/KEvJIp5TfI

— BrainStorm (@BrainstormCell) April 10, 2025